Comparative in vitro activities of nemonoxacin, doripenem, tigecycline and 16 other antimicrobials against Nocardia brasiliensis, Nocardia asteroides and unusual Nocardia species

Journal of Antimicrobial Chemotherapy

Volumn 64, Issue 1, 2009, Pages 73-78

  Lai, Chih Cheng ^a   Tan, Che Kim ^b   Lin, Sheng Hsiang ^c   Liao, Chun Hsing ^d   Chou, Chien Hong ^e   Hsu, Hsiao Leng ^e   Huang, Yu Tsung ^e   Hsueh, Po Ren ^e  

^a Yi Min Hospital   (Taiwan)

^b CHI MEI MEDICAL CENTER   (Taiwan)

^c Taipei County Hospital   (Taiwan)

^d FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Antimicrobial susceptibilities; Linezolid; Nocardiosis; Quinolones

Indexed keywords

AMIKACIN; AMOXICILLIN PLUS CLAVULANIC ACID; AZITHROMYCIN; BACTERIAL RNA; CARBAPENEM; CEFOXITIN; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DAPTOMYCIN; DORIPENEM; ERTAPENEM; GEMIFLOXACIN; IMIPENEM; LEVOFLOXACIN; LINEZOLID; MEROPENEM; MOXIFLOXACIN; NEMONOXACIN; QUINOLINE DERIVED ANTIINFECTIVE AGENT; RNA 16S; TG 873870; TIGECYCLINE; UNCLASSIFIED DRUG; VANCOMYCIN;

ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DRUG EFFICACY; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NOCARDIA; NOCARDIA ASTEROIDES; NOCARDIA BEIJINGENSIS; NOCARDIA BRASILIENSIS; NOCARDIA FARCINICA; NOCARDIA FLAVOROSEA; NOCARDIA JINANENSIS; NOCARDIA NOVA; NOCARDIA OTITIDISCAVIARUM; NOCARDIA PURIS; NOCARDIA TAKEDENSIS; NONHUMAN; RNA SEQUENCE; SPECIES DIFFERENCE;

ANTI-BACTERIAL AGENTS; DNA, BACTERIAL; DNA, RIBOSOMAL; HUMANS; MICROBIAL SENSITIVITY TESTS; NOCARDIA; NOCARDIA INFECTIONS; RNA, RIBOSOMAL, 16S; SEQUENCE ANALYSIS, DNA;

EID: 67249150477     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkp144     Document Type: Article

References (20)

1. Brown-Elliott BA, Brown JM, Conville PS et al. Clinical and laboratory features of the Nocardia spp. based on current molecular taxonomy. Clin Microbiol Rev 2006; 19: 259-82.
2. Arabi Y, Fairfax MR, Szuba MJ et al. Adrenal insufficiency, recurrent bacteremia, and disseminated abscesses caused by Nocardia asteroides in a patient with acquired immunodeficiency syndrome. Diagn Microbiol Infect Dis 1996; 24: 47-51.
3. Esteban J, Ramos JM, Fernandez-Gurrero ML et al. Isolation of Nocardia sp. from blood cultures in a teaching hospital. Scand J Infect Dis 1994; 26: 693-6.
4. Benbow EP Jr, Smith DT, Grimson KS. Sulfonamide therapy in actinomycosis: Two cases caused by aerobic partially acid-fast actinomyces. Am Rev Tuberc 1944; 49: 395-407.
5. Glover RP, Herrell WE, Heilman FR et al. Nocardia asteroides infection simulating pulmonary tuberculosis. JAMA 1948; 136: 172-5.
6. Wallace RJ Jr, Septimus EJ, Williams TW Jr et al. Use of trimethoprim-sulfamethoxazole for treatment of infections due to Nocardia. Rev Infect Dis 1982; 4: 315-25.
7. Wallace RJ Jr, Tsukamura M, Brown BA et al. Cefotaxime-resistant Nocardia asteroides strains are isolates of the controversial species Nocardia farcinica. J Clin Microbiol 1990; 28: 2726-32.
8. Welsh O, Vera-Cabrera L, Salinas-Carmona MC. Mycetoma. Clin Dermatol 2007; 25: 195-202.
9. Chen SJ, Lin L, Chang LW. Analysis of antibacterial response of nemonoxacin (TG-873870) against major pathogens from respiratory tract and skin infections. In: Abstracts of the Forty-fifth Annual Meeting of the Infectious Diseases Society of America, San Diego 2007. Abstract #441. Infectious Diseases Society of America, Arlington, VA, USA.
10. Rodríguez-Nava V, Couble A, Devulder G et al. Use of PCR-restriction enzyme pattern analysis and sequencing database for hsp65 gene-based identification of Nocardia species. J Clin Microbiol 2006; 44: 536-46.
11. National Committee for Clinical Laboratory Standards. Susceptibility Testing of Mycobacteria, Nocardiae, and Other Aerobic Actinomycetes. Approvdd Standard M24-A. NCCLS, Wayne, PA, USA, 2003.
12. Fuchs PC, Barry AL, Brown SD. Daptomycin susceptibility tests: interpretive criteria, quality control, and effect of calcidim on in vitro tests. Diagn Microbiol Infect Dis 2000; 38: 51-8.
13. Gomez-Flores A, Welsh O, Said-Fernández S et al. In vitro and in vivo activities of antimicrobials against Nocardia brasiliensis. Antimicrob Agents Chemother 2004; 48: 832-7.
14. Vera-Cabrera L, Gomez-Flores A, Escalante-Fuentes WG et al. In vitro activity of PNU-100766 (linezolid), a new oxazolidinone antimicrobial, against Nocardia brasiliensis. Antimicrob Agents Chemother 2001; 45: 3629-30.
15. Brown-Elliott BA, Ward SC, Crist CJ et al. In vitro activities of linezolid against multiple Nocardia species. Antimicrob Agents Chemother 2001; 45: 1295-7.
16. Glupczynski Y, Berhin C, Janssens M et al. Determination of antimicrobial susceptibility patterns of Nocardia spp. from clinical specimens by Etest. Clin Microbiol Infect 2006; 12: 905-12.
17. Huang YT, Liao CH, Teng LJ et al. Daptomycin susceptibility of unusual Gram-positive bacteria: Comparison of results obtained by the Etest and the broth microdilution method. Antimicrob Agents Chemother 2007; 51: 1570-2.
18. Cercenado E, Marín M, Sánchez-Martínez M et al. In vitro activities of tigecycline and eight other antimicrobials against different Nocardia species identified by molecular methods. Antimicrob Agents Chemother 2007; 51: 1102-4.
19. Wallace RJ Jr, Nash DR, Johnson WK et al. β-Lactam resistance in Nocardia brasiliensis is mediated by β-lactamase and reversed in the presence of clavulanic acid. J Infect Dis 1987; 156: 959-66.
20. Wexler HM, Engel AE, Glass D et al. In vitro activities of doripenem and comparator agents against 364 anaerobic clinical isolates. Antimicrob Agents Chemother 2005; 49: 4413-7.